Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medi-Caps's ROE % for the quarter that ended in Mar. 2026 was 10.90%. Medi-Caps's PB Ratio for the quarter that ended in Mar. 2026 was 0.26.
Medi-Caps's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 41.92%.
Medi-Caps ROE % Adjusted to Book Value Related Terms
Medi-Caps ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Medi-Caps's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medi-Caps ROE % Adjusted to Book Value Competitor Comparison
For the Real Estate - Diversified subindustry, Medi-Caps's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medi-Caps ROE % Adjusted to Book Value vs Real Estate Industry
For the Real Estate industry and Real Estate sector, Medi-Caps's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Medi-Caps's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 41.92% mean?
Medi-Caps (BOM:523144) has a ROE % Adjusted to Book Value of 41.92% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Medi-Caps and its competitors.
Is Medi-Caps' ROE % Adjusted to Book Value too high?
Medi-Caps' current ROE % Adjusted to Book Value is 41.92%. Overall, Medi-Caps has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medi-Caps' ROE % Adjusted to Book Value compare to competitors?
Medi-Caps' ROE % Adjusted to Book Value of 41.92% can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Real Estate company?
A good ROE % Adjusted to Book Value depends on the Real Estate industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Medi-Caps and its competitors. Medi-Caps's current ROE % Adjusted to Book Value is 41.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medi-Caps stock overvalued right now?
Based on GuruFocus' analysis, Medi-Caps (BOM:523144) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹19.90, compared to a current price of ₹26.26 — trading 32% above its estimated fair value. The current ROE % Adjusted to Book Value is 41.92%. Medi-Caps' overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Medi-Caps (BOM:523144), the current ROE % Adjusted to Book Value is 41.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medi-Caps (BOM:523144) Overvalued in 2026?
Based on GuruFocus' analysis, Medi-Caps stock appears to be overvalued.
The current stock price of ₹26.26 is trading 32% above its estimated GF Value™ of ₹19.90.
GuruFocus considers Medi-Caps to be Significantly Overvalued.
Key valuation signals for BOM:523144:
ROE % Adjusted to Book Value: 41.92%
GF Value™: ₹19.90 vs. price of ₹26.26 (32% above fair value)
No single metric tells the full story. See the BOM:523144 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medi-Caps Ltd is an India-based company engaged in the real estate business witch city centric developments by way of Strategic Land acquisition and developing the residential and commercial properties. Its project include Medicaps Business Park. The group has two segments namely, the Pharma Division, and the Real Estate Division. The majority of its revenue is generated from the Pharma Division.
47GF Score
Get the complete analysis for BOM:523144
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523144 has been successfully added to your 
